The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma-Reference-Cited by-同舟云学术

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

Published:2011-10 Issue:4 Volume:94 Page:321-333
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Johnson Sarah K.,Heuck Christoph J.,Albino Anthony P.,Qu Pingping,Zhang Qing,Barlogie Bart,Shaughnessy John D.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-011-0948-y.pdf

Reference76 articles.

1. Palumbo A, Anderson KC. Multiple myeloma. N Engl J Med. 2011;364:1046–60.

2. Barlogie B, Zangari M, Bolejack V, Hollmig K, Anaissie E, van RF, et al. Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma. Clin Lymphoma Myeloma. 2006;6:469–74.

3. Anderson KC. Oncogenomics to target myeloma in the bone marrow microenvironment. Clin Cancer Res. 2011;17:1225–33.

4. Palumbo A, Attal M, Roussel M. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival. Clin Cancer Res. 2011;17:1253–63.

5. Lonial S, Mitsiades CS, Richardson PG. Treatment options for relapsed and refractory multiple myeloma. Clin Cancer Res. 2011;17:1264–77.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma;International Journal of Molecular Sciences;2023-09-26

2. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients;International Journal of Cancer;2021-03-30

3. Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma;Modern Pathology;2019-08-02

4. Introductory Chapter: Multiple Myeloma in the Era of Novel Therapeutics;Update on Multiple Myeloma;2019-02-20

5. Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Therapies;Update on Multiple Myeloma;2019-02-20